Top Markets
Coin of the day
ATyr Pharma, Inc. ATyr Pharma, Inc.

ATyr Pharma, Inc.

ATYR
Classifica tra le azioni #25448
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego,... aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis and ILDs linked to connective tissue diseases. Beyond its lead candidate, aTyr Pharma's pipeline features ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical stages of development for combating fibrosis. The company is also progressing with ATYR0750, a domain sourced from alanyl-tRNA synthetase, intended for the management of liver disorders. Furthermore, aTyr Pharma has entered into a strategic collaboration and licensing agreement with Kyorin Pharmaceutical Co., Ltd. This partnership is focused on the development and commercialization of efzofitimod for interstitial lung diseases specifically within the Japanese market.
Prezzo delle azioni
$0.5049
Ultima sincronizzazione: 2026-08-20
Capitalizzazione di mercato
$49.51M
Variazione (1 giorno)
-5.24%
Variazione (1 anno)
-89.80%
Paese
US
Scambia ATyr Pharma, Inc. (ATYR)

Categoria

Storico del prezzo dell'azione per ATyr Pharma, Inc. (ATYR)
Prezzo di chiusura più alto: $0.53 il 2026-08-01

Prezzo di chiusura più basso: $1.73 il 2024-05-01
Storico del prezzo dell'azione di ATyr Pharma, Inc. dal 2024 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 37.71%
2025 -77.30%
2024 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$539.14 35.65%
US
$1.04K 56.21%
NL
$117.80 -18.86%
AU
$761.87 8.65%
CH
$130.43 397.46%
US